Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)
CNY 2.58
(-1.15%)
CNY 2.58
(-1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -39.26 Million | -14.44 Million | -14.8 Million | -6.77 Million | 4.04 Million | 31.69 Million |
| Net Income | -84.26 Million | -73.52 Million | -7.46 Million | 7.75 Million | -23.93 Million | 13.82 Million |
| Depreciation & Amortization | 30.58 Million | 29.78 Million | 30.83 Million | 28.26 Million | 26.19 Million | 22.79 Million |
| Deferred income taxes | 1.63 Million | 4.69 Million | -678.48 Thousand | -511.74 Thousand | 1.75 Million | 1.57 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.2 Million | 6.27 Million | -42.28 Million | -39.69 Million | -24.21 Million | -8.07 Million |
| Other non-cash items | 233.65 Thousand | 23.02 Million | 4.1 Million | -3.1 Million | 25.99 Million | 3.15 Million |
| Investing Cash Flow | 56.04 Million | 115.99 Million | -29.56 Million | -95.73 Million | -216.79 Million | 293.71 Million |
| Investments in PPE | -15.66 Million | -25.22 Million | -10.35 Million | -23.6 Million | -7.07 Million | -15.53 Million |
| Acquisitions | 14.6 Million | 17.71 Million | 11.72 Million | 23.95 Million | -25.93 Million | -13.72 Million |
| Investment purchases | -1.25 Billion | -1.02 Billion | -1.16 Billion | -1.16 Billion | -2.05 Billion | -423.52 Million |
| Sales/Maturities of investments | 1.35 Billion | 1.14 Billion | 1.13 Billion | 1.09 Billion | 1.86 Billion | 732.76 Million |
| Other Investing Activities | -24.69 Million | 343.2 Thousand | 414.4 Thousand | -23.6 Million | 0.76 | 13.72 Million |
| Financing Cash Flow | 2.88 Million | -12.52 Million | 22.43 Million | 31.06 Million | 23.9 Million | -12.01 Million |
| Debt repayment | -11 Million | -225 Thousand | -10 Million | - | - | - |
| Dividends payments | - | - | -393.58 Thousand | - | - | -12.01 Million |
| Common Stock Repurchased | -670 Thousand | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.93 Million | -12.29 Million | 32.82 Million | 31.06 Million | 23.9 Million | 13.72 Million |
| Accounts receivables | 7.75 Million | 13.28 Million | -94.55 Million | -11.29 Million | 5.42 Million | 3.03 Million |
| Accounts payables | -14.95 Million | -3.41 Million | 32.44 Million | -7.69 Million | -17.25 Million | -10.99 Million |
| Inventory | -1.64 Million | -8.29 Million | 20.5 Million | -20.19 Million | -14.14 Million | 2.68 Million |
| Other working capital | 69.8 Thousand | 4.69 Million | -678.48 Thousand | -511.74 Thousand | 1.75 Million | -10.76 Million |
| Cash at beginning of period | 191.07 Million | 102.03 Million | 123.97 Million | 195.42 Million | 384.28 Million | 70.88 Million |
| Cash at end of period | 210.73 Million | 191.07 Million | 102.03 Million | 123.97 Million | 195.42 Million | 384.28 Million |
| Capital Expenditure | -15.66 Million | -25.22 Million | -10.35 Million | -23.6 Million | -7.07 Million | -15.53 Million |
| Effect of forex changes on cash | - | 0.88 | 0.56 | 0.42 | - | 1.00 |
| Net cash flow / Change in cash | 19.66 Million | 89.03 Million | -21.93 Million | -71.45 Million | -188.85 Million | 313.39 Million |
| Free Cash Flow | -54.92 Million | -39.66 Million | -25.15 Million | -30.38 Million | -3.03 Million | 16.16 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.1 Million | 267.77 Thousand | -4.49 Million | -44.29 Million | -84.26 Million | -10.86 Million |
| Depreciation & Amortization | - | 4.17 Million | 4.17 Million | 30.58 Million | 30.58 Million | -15.78 Million |
| Deferred income taxes | - | - | - | - | 1.63 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -17.23 Million | - | 6.18 Million | -7.2 Million | 9.14 Million |
| Other non-cash items | 3.58 Million | -21.18 Million | 633.04 Thousand | 16.15 Million | 233.65 Thousand | 12.37 Million |
| Investing Cash Flow | 878.53 Thousand | 171.44 Million | -87.2 Million | 109.02 Million | 56.04 Million | -1.89 Million |
| Investments in PPE | -177.92 Thousand | -1.89 Million | -2.34 Million | -3.56 Million | -15.66 Million | -2.2 Million |
| Acquisitions | 205 Thousand | 38 Thousand | - | 5.05 Million | 14.6 Million | 3.08 Million |
| Investment purchases | -21.37 Million | -166 Million | -419.01 Million | -210.7 Million | -1.25 Billion | -301.5 Million |
| Sales/Maturities of investments | 22.22 Million | 335.3 Million | 334.15 Million | 342.93 Million | 1.35 Billion | 301.8 Million |
| Other Investing Activities | - | 4 Million | -83.95 Million | 107.54 Million | -24.69 Million | -3.08 Million |
| Financing Cash Flow | -7.1 Million | -2.11 Million | 9.98 Million | -155 Thousand | 2.88 Million | 3.08 Million |
| Debt repayment | - | -4 Million | -9.98 Million | - | -11 Million | - |
| Dividends payments | - | -112.26 Thousand | - | - | - | - |
| Common Stock Repurchased | - | - | - | -670 Thousand | -670 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.1 Million | -112.26 Thousand | 9.98 Million | -155 Thousand | 2.93 Million | 3.08 Million |
| Accounts receivables | - | -5.02 Million | - | 7.75 Million | 7.75 Million | 4.13 Million |
| Accounts payables | - | - | - | - | -14.95 Million | -1.31 Million |
| Inventory | - | -897.7 Thousand | - | -1.64 Million | -1.64 Million | 5 Million |
| Other working capital | - | -11.31 Million | - | 69.8 Thousand | 69.8 Thousand | 1.31 Million |
| Cash at beginning of period | 272.68 Million | 129.65 Million | 93.23 Million | 93.23 Million | 191.07 Million | 98.73 Million |
| Cash at end of period | 264.92 Million | 272.68 Million | 129.65 Million | 210.73 Million | 210.73 Million | 93.23 Million |
| Capital Expenditure | -177.92 Thousand | -1.89 Million | -2.34 Million | -3.56 Million | -15.66 Million | -2.2 Million |
| Effect of forex changes on cash | - | - | - | - | - | -1.55 Million |
| Net cash flow / Change in cash | -7.75 Million | 143.02 Million | 36.42 Million | 117.5 Million | 19.66 Million | -5.49 Million |
| Free Cash Flow | -1.69 Million | -26.98 Million | -6.2 Million | 5.06 Million | -54.92 Million | -7.33 Million |
MGAAF
301129
ARRNF
JYOTHYLAB
KTYCF
0J86